The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) Sarcoma Groups phase I/II trial of sunitinib plus nivolumab in selected bone and soft tissue sarcoma subtypes—Results of the phase I part.
 
Javier Martin Broto
Consulting or Advisory Role - Bayer; Lilly; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - Eisai (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Nadia Hindi
Research Funding - Eisai (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Andres Redondo
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; PharmaMar; Roche; Tesaro
Research Funding - Roche
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Javier Martinez-Trufero
Consulting or Advisory Role - Eisai; Lilly; Merck; PharmaMar
Travel, Accommodations, Expenses - Merck; PharmaMar
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Emanuela Palmerini
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Lilly
Research Funding - Daiichi Sankyo; PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Takeda
 
Enrique Alava
No Relationships to Disclose
 
David Silva Moura
Research Funding - Eisai (Inst); Novartis (Inst); PharmaMar (Inst)
 
Herminia Perez Vega
No Relationships to Disclose
 
Irene Otero
No Relationships to Disclose
 
Patricio Ledesma
No Relationships to Disclose
 
Emanuela Marchesi
No Relationships to Disclose
 
Jose A. Lopez-Martin
Stock and Other Ownership Interests - PharmaMar
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Caris Life Sciences; Celgene; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - MSD Oncology; Roche